TY - JOUR
T1 - Number of osteoclasts, receptor activator of nuclear factor kappa-b ligand and osteoprotegerin expression in electrolyzed reduced water-treated orthodontic tooth movement in Wistar rats
AU - Putranto, Ananda Firman
AU - Roestamadji, Retno Indrawati
AU - Ridwan, Rini Devijanti
AU - Narmada, Ida Bagus
N1 - Publisher Copyright:
© 2019 The authors. This work is licensed under the Creative Commons Trop J Pharm Attribution Res, November 4.0 International 2019; 18(11): License2397
PY - 2019
Y1 - 2019
N2 - Purpose: To analyse the potential use of electrolyzed reduced water effect (ERW) in the treatment of orthodontic tooth movement in Wistar rats by means of osteoclast number, receptor activator of nuclear factor kappa-B ligand (RANKL) and osteoprotegerin (OPG) expressions. Methods: ERW was produced by an electrolysis machine that rendered the water pH alkaline. A dose of ERW 2.5 ml/100 g body weight was used for treatment for 7 days. The orthodontic tooth movement animal study was done by means of a rubber separator, with 0.0284 N force applied to the maxillary incisive tooth for 7 days. The rats were euthanized on days 3, 5 and 7 with the maxilla bone subsequently removed for immunohistochemistry examination. RANKL and OPG expression were evaluated by immunohistochemical staining and the osteoclast number determined with the aid of haematoxylin-eosin stain. Results: ERW decreased the osteoclast number in the treatment group on day 3 and OPG expression on day 7 and there was significant difference between the groups (p < 0.05). RANKL expression decreased on Day 7. There was a significant difference between treatment groups on Days 5 and 7. Conclusion: ERW significantly inhibits the number of osteoclasts, RANKL and OPG expression during orthodontic tooth movement after 3 and 7 days. ERW is thus a potential therapy for enhancement of bone remodeling in patients with orthodontic tooth movement.
AB - Purpose: To analyse the potential use of electrolyzed reduced water effect (ERW) in the treatment of orthodontic tooth movement in Wistar rats by means of osteoclast number, receptor activator of nuclear factor kappa-B ligand (RANKL) and osteoprotegerin (OPG) expressions. Methods: ERW was produced by an electrolysis machine that rendered the water pH alkaline. A dose of ERW 2.5 ml/100 g body weight was used for treatment for 7 days. The orthodontic tooth movement animal study was done by means of a rubber separator, with 0.0284 N force applied to the maxillary incisive tooth for 7 days. The rats were euthanized on days 3, 5 and 7 with the maxilla bone subsequently removed for immunohistochemistry examination. RANKL and OPG expression were evaluated by immunohistochemical staining and the osteoclast number determined with the aid of haematoxylin-eosin stain. Results: ERW decreased the osteoclast number in the treatment group on day 3 and OPG expression on day 7 and there was significant difference between the groups (p < 0.05). RANKL expression decreased on Day 7. There was a significant difference between treatment groups on Days 5 and 7. Conclusion: ERW significantly inhibits the number of osteoclasts, RANKL and OPG expression during orthodontic tooth movement after 3 and 7 days. ERW is thus a potential therapy for enhancement of bone remodeling in patients with orthodontic tooth movement.
KW - Electrolyzed reduced water
KW - Orthodontic tooth movement
KW - Osteoclast
KW - Osteoprotegerin
KW - RANKL
UR - http://www.scopus.com/inward/record.url?scp=85077872737&partnerID=8YFLogxK
U2 - 10.4314/tjpr.v18i11.24
DO - 10.4314/tjpr.v18i11.24
M3 - Article
AN - SCOPUS:85077872737
SN - 1596-5996
VL - 18
SP - 2397
EP - 2402
JO - Tropical Journal of Pharmaceutical Research
JF - Tropical Journal of Pharmaceutical Research
IS - 11
ER -